Welcome to LookChem.com Sign In|Join Free

CAS

  • or

705-14-6

Post Buying Request

705-14-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

705-14-6 Usage

Class of compounds

Derivative of amphetamine and phenethylamine, structurally related to opioids

Psychoactive properties

Potential psychoactive properties

Effects on the central nervous system

Stimulating effects on the central nervous system

Potential medical uses

May have potential as a therapeutic agent for conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy

Regulatory concerns

Its psychoactive effects and potential for abuse and addiction make it a subject of concern for regulatory authorities

Current status

Research into its pharmacological properties and potential medical uses is ongoing.

Check Digit Verification of cas no

The CAS Registry Mumber 705-14-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,0 and 5 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 705-14:
(5*7)+(4*0)+(3*5)+(2*1)+(1*4)=56
56 % 10 = 6
So 705-14-6 is a valid CAS Registry Number.

705-14-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name α-cyclopropyl-4-fluorobenzylamine

1.2 Other means of identification

Product number -
Other names (4-fluorophenyl)(cyclopropyl)methanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:705-14-6 SDS

705-14-6Relevant articles and documents

METALLOENZYME INHIBITOR COMPOUNDS

-

, (2018/09/28)

Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 705-14-6